UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Non-Hodgkin lymphoma

The Lancet (British edition), 2012-09, Vol.380 (9844), p.848-857

2012

Link zum Volltext

Verfügbarkeit prüfen

Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4096-4104

2011

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach

The lancet oncology, 2018-01, Vol.19 (1), p.e56-e64

2018

Link zum Volltext

Verfügbarkeit prüfen

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

JNCI : Journal of the National Cancer Institute, 2007-02, Vol.99 (3), p.206-214

2007

Link zum Volltext

Verfügbarkeit prüfen

Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5390-5396

2009

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study

Journal of clinical oncology, 2012-08, Vol.30 (22), p.2745-2752

2012

Link zum Volltext

Verfügbarkeit prüfen

Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519)

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3352-3359

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1568-1574

2006

Link zum Volltext

Verfügbarkeit prüfen

Placental site trophoblastic tumour and epithelioid trophoblastic tumour

Best practice & research. Clinical obstetrics & gynaecology, 2021-07, Vol.74, p.131-148

2021

Link zum Volltext

Verfügbarkeit prüfen

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Cochrane database of systematic reviews, 2016-06, Vol.2016 (6), p.CD007102

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9208-9218

2005

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Cochrane database of systematic reviews, 2016-01, Vol.2016 (1), p.CD008891

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment of metastatic gestational trophoblastic neoplasia

The lancet oncology, 2007-08, Vol.8 (8), p.715-724

2007

Link zum Volltext

Verfügbarkeit prüfen

M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia

International journal of cancer, 2021-05, Vol.148 (9), p.2335-2344

2021

Link zum Volltext

Verfügbarkeit prüfen

PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?

International journal of cancer, 2023-03, Vol.152 (5), p.986-997

2023

Link zum Volltext

Verfügbarkeit prüfen

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Cochrane database of systematic reviews, 2012-07 (7), p.CD007102

2012

Link zum Volltext

Verfügbarkeit prüfen

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours

British journal of cancer, 2019-03, Vol.120 (6), p.587-594

2019

Link zum Volltext

Verfügbarkeit prüfen

PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia

Gynecologic oncology, 2024-01, Vol.180, p.152-159

2024

Link zum Volltext

Verfügbarkeit prüfen

Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2023-02, Vol.169, p.34-40

2023

Link zum Volltext

Verfügbarkeit prüfen

Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia

British journal of cancer, 2021-03, Vol.124 (6), p.1066-1071

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Cochrane database of systematic reviews, 2012-12, Vol.12, p.CD008891

2012

Link zum Volltext

Verfügbarkeit prüfen

Risk of premature menopause after treatment for Hodgkin's lymphoma

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma

Clinical cancer research, 2006-11, Vol.12 (21), p.6480-6486

2006

Link zum Volltext

Verfügbarkeit prüfen

Experiences of Women With Gestational Trophoblastic Neoplasia Treated With High-Dose Chemotherapy and Stem Cell Transplantation: A Qualitative Study

Oncology nursing forum, 2017-05, Vol.44 (3), p.375

2017

Link zum Volltext

Verfügbarkeit prüfen

First line chemotherapy in low risk gestational trophoblastic neoplasia

Cochrane database of systematic reviews, 2009-01 (1), p.CD007102

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(103)
Humans
(99)
Female
(66)
Biological And Medical Sciences
(51)
Oncology
(51)
Medical Sciences
(48)
Pregnancy
(41)
Adult
(39)
Middle Aged
(29)
Obstetrics & Gynecology
(28)
Male
(23)
Gynecology. Andrology. Obstetrics
(20)
Retrospective Studies
(20)
Gestational Trophoblastic Disease - Drug Therapy
(19)
Aged
(17)
Chemotherapy
(17)
Hematologic And Hematopoietic Diseases
(17)
Adolescent
(16)
Hematology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Non-Hodgkin lymphoma

Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study

Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study

Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519)

Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study

Placental site trophoblastic tumour and epithelioid trophoblastic tumour

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Treatment of metastatic gestational trophoblastic neoplasia

M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia

PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours

PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia

Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia

Computed tomography chest imaging offers no advantage over chest X-ray in the initial assessment of gestational trophoblastic neoplasia

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Risk of premature menopause after treatment for Hodgkin's lymphoma

Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma

Experiences of Women With Gestational Trophoblastic Neoplasia Treated With High-Dose Chemotherapy and Stem Cell Transplantation: A Qualitative Study

First line chemotherapy in low risk gestational trophoblastic neoplasia

Suchergebnisse filtern